Gene Editing Technology

Intellia, CRISPR-based and Gene Editing

Milestone for Crispr: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling condition has succeeded in a Phase 3 trial, marking a major milestone for the technology.

· 2d

Intellia Drug Hits Goal in Milestone for Gene Editing Technology

· 2d · on MSN

Intellia Therapeutics says its CRISPR-based treatment succeeds in pivotal trial

New genome editing method could swap entire genes and correct 1000 mutations at once

New technology enables the insertion of a large segment of DNA into a genome, potentially expanding gene therapy treatment ...

The Economist

Genome editing can be risky. Meet the epigenome editors

That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox– Additional presentations ...

Healio

Advanced gene editing ‘promising’ for sickle cell disease, but access challenges remain

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

New gene-editing tool allows scientists to cut out cancerous DNA without harming healthy cells

Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...

Nasdaq

Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization

BEIJING, Dec. 2, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that its pioneering corn ...

Show inaccessible results